<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-5696</issn><issn publication-format="electronic">2079-5831</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">34287</article-id><article-id pub-id-type="doi">10.26442/20795696.2020.5.200365</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Promising directions of medical technologies for the correction of sleep disorders in menopausal women of various ethnic groups</article-title><trans-title-group xml:lang="ru"><trans-title>Перспективные направления медицинских технологий коррекции нарушений сна в климактерическом периоде у женщин различных этнических групп</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6512-1335</contrib-id><name-alternatives><name xml:lang="en"><surname>Semenova</surname><given-names>Natalia V.</given-names></name><name xml:lang="ru"><surname>Семенова</surname><given-names>Наталья Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Biol.), Scientific Center for Family Health and Human Reproduction Problems</p></bio><bio xml:lang="ru"><p>д-р биол. наук, вед. науч. сотр. лаб. патофизиологии ФГБНУ НЦ ПЗСРЧ</p></bio><email>natkor_84@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3423-7260</contrib-id><name-alternatives><name xml:lang="en"><surname>Madaeva</surname><given-names>Irina M.</given-names></name><name xml:lang="ru"><surname>Мадаева</surname><given-names>Ирина Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Scientific Centre for Family Health and Human Reproduction Problems</p></bio><bio xml:lang="ru"><p>д-р мед. наук, гл. науч. сорт. лаб. сомнологии и нейрофизиологии ФГБНУ НЦ ПЗСРЧ</p></bio><email>nightchild@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3354-2992</contrib-id><name-alternatives><name xml:lang="en"><surname>Kolesnikova</surname><given-names>Lyubov I.</given-names></name><name xml:lang="ru"><surname>Колесникова</surname><given-names>Любовь Ильинична</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Acad. RAS, Scientific Center for Family Health and Human Reproduction Problems</p></bio><bio xml:lang="ru"><p>акад. РАН, д-р мед. наук, проф., науч. рук. ФГБНУ НЦ ПЗСРЧ</p></bio><email>iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Scientific Center for Family Health and Human Reproduction Problems</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2020</year></pub-date><volume>22</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>31</fpage><lpage>36</lpage><history><date date-type="received" iso-8601-date="2020-06-02"><day>02</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://gynecology.orscience.ru/2079-5831/article/view/34287">https://gynecology.orscience.ru/2079-5831/article/view/34287</self-uri><abstract xml:lang="en"><p>ethnic groups.</p> <p><bold>Materials and methods. </bold>The objects of the study were menopausal women of Russian and Buryat ethnic groups (n=466), who were divided into a control group (without sleep disturbances) and main subgroups (with insomnia and comorbidity of insomnia with obstructive sleep apnea syndrome). All women underwent clinical and anamnestic examination, genotyping for <italic>3111T</italic>/C Clock gene polymorphism, determination of the circadian profile of melatonin secretion, parameters of lipid metabolism and the system «lipid peroxidation – antioxidant protection».</p> <p><bold>Results. </bold>In Caucasians with sleep disorders, a higher prevalence of the <italic>3111T</italic>/T genotype and the <italic>Clock</italic> gene <italic>3111T</italic> allele was revealed as compared to the control (<italic>p</italic>&lt;0.05). Perimenopausal Caucasians showed a shift in the peak of melatonin secretion to the morning hours; in Mongoloids, both peri- and postmenopausal women, a decrease in melatonin total levels was revealed. Dyslipoproteinemia is characteristic of both races patients who have comorbidity of insomnia and obstructive sleep apnea syndrome, and it is more pronounced in postmenopausal Caucasians. Oxidative stress in sleep disorders is more pronounced in Mongoloids. The medical technologies directions for correction of sleep disorders are proposed: the use of melatonin drugs in the evening and light therapy in the early morning hours in Caucasians who are carriers of the <italic>3111T Clock</italic> gene allele; melatonin drugs to increase its total level in Mongoloids; personalized prescription of antioxidant therapy in all patients; specific therapy to eliminate breathing disorders during sleep in those who have obstructive sleep apnea syndrome.</p> <p><bold>Conclusions. </bold>Presence of insomnia, chronobiological rhythms of melatonin secretion, lipid peroxidation processes in sleep disorders are ethnospecific.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель.</bold><bold> </bold>Разработать перспективные направления патогенетической коррекции нарушений сна в климактерическом периоде у женщин двух этнических групп.</p> <p><bold>Материалы и методы.</bold><bold> </bold>Объектами исследования явились женщины климактерического периода русской и бурятской этнических групп (n=466), которые были разделены на контрольную группу (без нарушений сна) и основные подгруппы (с инсомнией и коморбидностью инсомнии с синдромом обструктивного апноэ сна). Всем женщинам провели клинико-анамнестическое обследование, генотипирование полиморфизма <italic>3111</italic><italic>T</italic><italic>/</italic><italic>C </italic>гена <italic>Clock</italic>, определение циркадного профиля секреции мелатонина, параметров липидного обмена и системы «перекисное окисление липидов–антиоксидантная защита».</p> <p><bold>Результаты.</bold><bold> </bold>У европеоидов с нарушениями сна выявлена большая распространенность <italic>3111Т/Т</italic>-генотипа и <italic>3111Т</italic>-аллеля гена <italic>Clock</italic> по сравнению с контролем (<italic>p</italic>&lt;0,05). В перименопаузе у европеоидов выявили смещение пика секреции мелатонина на утренние часы, у монголоидов как в пери-, так и в постменопаузе отмечено общее снижение уровней мелатонина. Для пациенток обеих рас при коморбидности инсомнии и синдрома обструктивного апноэ сна характерно развитие дислипопротеидемии, что в постменопаузе более выражено у европеоидов. Окислительный стресс при нарушениях сна более выражен у монголоидов. Предложены направления медицинских технологий коррекции нарушений сна: для европеоидов – носителей <italic>3111Т</italic>-аллеля гена <italic>Clock </italic>– применение препаратов мелатонина в вечернее время суток и светотерапия в ранние утренние часы; для монголоидов – препараты мелатонина для общего повышения его уровня; персонализированное назначение антиоксидантной терапии для всех пациенток; при наличии синдрома обструктивного апноэ сна – специфическая терапия для устранения нарушений дыхания во время сна.</p> <p><bold>Заключение.</bold><bold> </bold>Наличие инсомнии, хронобиологические ритмы секреции мелатонина, течение процессов липопероксидации при нарушениях сна обладают этноспецифичностью.</p></trans-abstract><kwd-group xml:lang="en"><kwd>sleep disorders</kwd><kwd>menopausal</kwd><kwd>ethnicity</kwd><kwd>melatonin</kwd><kwd>oxidative stress</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нарушения сна</kwd><kwd>климактерий</kwd><kwd>этнос</kwd><kwd>мелатонин</kwd><kwd>окислительный стресс</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Xu Q, Lang CP. Examining the relationship between subjective sleep disturbance and menopause: a systematic review and meta-analysis. Menopause 2014; 21 (12): 1301–18. DOI: 10.1097/GME.0000000000000240</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Xie Z, Chen F, Li WA et al. A review of sleep disorders and melatonin. Neurol Res 2017; 39 (6): 559–65. DOI: 10.1080/01616412.2017.1315864</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Gulec M, Ozkol H, Selvi Y et al. Oxidative stress in patients with primary insomnia. Progr Neuropsychopharmacol Biol Rsychiatry 2012; 37 (2): 247–51. DOI: 10.1016/j.pnpbp.2012.02.011</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Liang B, Li Y-H, Kong H. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia. Eur Rev Mel Pharmacol Sci 2013; 17 (1): 2517–22.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain. Sleep Med Rev 2015; 20: 27–45. DOI: 10.1016/j.smrv.2014.07.003</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Jagannath A, Taylor L, Wakaf Z et al. The genetics of circadian rhythms, sleep and health. Hum Mol Gene 2017; 26 (R2): R128–38. DOI: 10.1093/hmg/ddx240</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Choub A, Mancuso M, Coppede F et al. Clock T3111C and Per2 C111G SNPs do not inﬂuence circadian rhythmicity in healthy Italian population. Neurol Sci 2011; 32: 89–93. DOI: 10.1007/s10072-010-0415-1</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Benedetti F, Dallaspezia S, Fulgosi MC. Actimetric evidence that Clock 3111T/C SNP influence sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 631–5.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Voinescu B, Thome J, Orasan R. The rs1801260 CLOCK polymorphism, links to depression, insomnia and diurnal preference-preliminary findings from a Romanian sample. HVM Bioflux 2009; 1 (2): 67–73.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Antypa N, Mandelli L, Nearchou FA et al. The 3111T/C polymorphism interacts with stressful life events to influence patterns of sleep in females. Chronobiol Int 2012; 29 (7): 891–7. DOI: 10.3109/07420528.2012.699380</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Сухих Г.Т., Сметник В.П., Юренева С.В. и др. Менопауза и климактерическое состояние у женщин. Клинические рекомендации. М.: НМИЦ АГП им. В.И. Кулакова, 2016. [Sukhikh G.T., Smetnik V.P., Yureneva S.V. et al. Menopause and climacteric state in women. Clinical guidelines. Moscow: Kulakov NMITs AGP, 2016 (In Russian).]</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Johns MW. New method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540–5.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Savard J, Simard S, Morin C. Insomnia. In: Formulation and treatment in clinical health psychology. Ed. A. Nikcevic, A. Kuczmierczyk, M. Bruch. London: Routledge. 2006; p. 61–86.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zavada A, Gordijn MC, Beersma DG et al. Comparison of the Munich Chronotype Questionnaire with the Horne-Ostberg’s Morningness-Eveningness Score. Chronobiol Int 2005; 22 (2): 267–78.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Полуэктов М.Г., Бузунов Р.В., Авербух В.М. и др. Проект клинических рекомендаций по диагностике и лечению хронической инсомнии у взрослых. Неврология и Ревматология (Прил. к журн. Consilium Medicum). 2016; 2: 41–51. [Poluektov M.G., Buzunov R.V., Averbukh V.M. et al. Draft clinical guidelines for the diagnosis and treatment of chronic insomnia in adults. Neurology and Rheumatology (Suppl. Consilium Medicum). 2016; 2: 41–51 (In Russian).]</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kolesnikova LI, Semyonova NV, Grebenkina LA et al. Integral indicator of oxidative stress in human blood. Bull Exp Biol Med 2014; 157 (6): 715–7. DOI: 10.1007/s10517-014-2649-z</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Гинекология. Национальное руководство. Под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова и др. М., 2019. [Gynecology. National leadership. Ed. G.M. Savelyeva, G.T. Sukhikh, V.N. Serova et al. Moscow, 2019 (In Russian).]</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Higuchi S, Motohashi Y, Ishibashi K, Maeda T. Influence of eye colors of Caucasians and Asians on suppression of melatonin secretion by light. Am J Physiol Regul Integr Comp Physiol 2007; 292 (6): R2352–6. DOI: 10.1152/ajpregu.00355.2006</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Scott EM, Carter AM, Grant PJ. Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond) 2008; 32 (4): 658–62. DOI: 10.1038/sj.ijo.0803778</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Caruso D, Masci I, Cipollone G, Palagini L. Insomnia and depressive symptoms during the menopausal transition: theoretical and therapeutic implications of a self-reinforcing feedback loop. Maturitas 2019; 123: 78–81. DOI: 10.1016/j.maturitas.2019.02.007</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Wang Y, Jiang T, Wang X et al. Association between Insomnia and Metabolic Syndrome in a Chinese Han Population: A Cross-sectional Study. Sci Rep 2017; 7 (1): 10893. DOI: 10.1038/s41598-017-11431-6</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Колесникова Л.И., Даренская М.А., Колесников С.И. Свободнорадикальное окисление: взгляд патофизиолога. Бюл. сибирской медицины. 2017; 16 (4): 16–29. [Kolesnikova LI, Darenskaya MA, Kolesnikov SI. Free radical oxidation: a pathophysiologist’s view. Bjulleten’ sibirskoj mediciny. 2017; 16 (4): 16–29 (In Russian).] DOI: 10.20538/1682-0363-2017-4-16-29</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Spielman A, Caruso L, Glovinsky P. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987; 10: 541–53.</mixed-citation></ref></ref-list></back></article>
